Form 8-K - Current report:
SEC Accession No. 0001493152-26-027047
Filing Date
2026-06-03
Accepted
2026-06-03 16:05:26
Documents
13
Period of Report
2026-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46618
2 EX-4.1 ex4-1.htm EX-4.1 100086
3 EX-10.1 ex10-1.htm EX-10.1 190462
  Complete submission text file 0001493152-26-027047.txt   548585

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE irme-20260603.xsd EX-101.SCH 3020
5 XBRL LABEL FILE irme-20260603_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE irme-20260603_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2741
Mailing Address C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE SUITE 500 NEW YORK NY 10151
Business Address C/O ABOUDI LEGAL GROUP PLLC, 745 5TH AVE SUITE 500 NEW YORK NY 10151 6467684285
IR-Med, Inc. (Filer) CIK: 0001839133 (see all company filings)

EIN.: 844516398 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56492 | Film No.: 261060593
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)